Martingale Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Martingale Asset Management's DGX Position: Q2 2023 in Review
Martingale Asset Management sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 1,426 shares — an estimated $202K sold.
Martingale Asset Management first reported a position in DGX in Q4 2013 and held it in 16 quarters. The position peaked at $2.75M in Q3 2017. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Martingale Asset Management reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
- Martingale Asset Management sold 1,426 Quest Diagnostics shares in Q2 2023, an estimated $202K.
- Martingale Asset Management first reported a position in Quest Diagnostics in Q4 2013 and held it in 16 quarters.
- Martingale Asset Management's Quest Diagnostics position peaked at $2.75M in Q3 2017.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Martingale Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.